368.02
price down icon0.04%   -0.2303
 
loading

Finanzdaten der Amgen Inc-Aktie (AMGN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
3.23%
9,866.00
9,557.00 9,179.00 8,149.00 8,503.00
Cost Of Revenue
3.44%
2,976.00
3,082.00 3,011.00 2,968.00 3,310.00
Gross Profit
6.41%
6,890.00
6,475.00 6,168.00 5,181.00 5,193.00
Operating Expenses
5.60%
4,170.00
3,949.00 3,512.00 4,003.00 3,146.00
Benefits Costs and Expenses
48.19%
8,352.00
5,636.00 7,611.00 6,176.00 5,402.00
Costs And Expenses
1.64%
7,146.00
7,031.00 6,523.00 6,971.00 6,456.00
Depreciation and Amortization
2.59%
226.00
232.00 220.00 209.00 -
Operating Income/Loss
7.68%
2,720.00
2,526.00 2,656.00 1,178.00 2,047.00
Nonoperating Income/Loss
126.59%
-553.00
2,080.00 -394.00 1,518.00 1,830.00
Income/Loss From Continuing Operations Before Tax
61.39%
1,514.00
3,921.00 1,568.00 1,973.00 3,101.00
Income Tax Expense/Benefit
74.33%
181.00
705.00 136.00 243.00 271.00
Income/Loss From Continuing Operations After Tax
58.55%
1,333.00
3,216.00 1,432.00 1,730.00 2,830.00
Net Income/Loss
58.55%
1,333.00
3,216.00 1,432.00 1,730.00 2,830.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
100.00%
-
538.00 538.00 538.00 537.00
Diluted Average Shares
100.00%
-
542.00 541.00 541.00 542.00
Basic Earnings Per Share
58.70%
2.47
5.98 2.66 3.22 5.27
Diluted Earnings Per Share
58.52%
2.46
5.93 2.65 3.20 5.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$145.75
price up icon 0.45%
drug_manufacturers_general NVO
$37.96
price down icon 0.11%
drug_manufacturers_general PFE
$26.75
price down icon 0.39%
drug_manufacturers_general MRK
$116.53
price up icon 0.65%
drug_manufacturers_general NVS
$153.81
price down icon 0.31%
Kapitalisierung:     |  Volumen (24h):